Allergan PLC (2015)
Also known as: Allergan, plc | Cady, Roger, M.D. | DBYAN Medicine Professional Corporation | Forest Laboratories, an Allergan affiliate | Roger Cady, M.D. | TransDerm, Inc. | VIOKACE | Viokace, LLC | Vitae Pharmaceuticals Inc., an Allergan affiliate
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2015First marketed drug
Jan 1, 2015First NDA
Oct 1, 2018Last known activity
Jun 24, 2019
Timeline
2000s
- Mar 23, 2006
Inamed GmbH— Acquired
2010s
- Jan 1, 2015
Allergan PLC (2015)— Founded
- Jan 1, 2015
Kythera— Acquired
- Mar 17, 2015
Actavis— Acquired
- Jul 6, 2015
Oculeve— Acquired
- Jul 27, 2015
Naurex— Acquired
- Oct 19, 2015
AqueSys— Acquired
- Jan 7, 2016
Anterios— Acquired
- Apr 22, 2016
Topokine Therapeutics— Acquired - Apr 29, 2016
azacitidine— NDA Secondary Org
- Aug 11, 2016
ForSight Vision 5— Acquired
- Sep 6, 2016
RetroSense Therapeutics— Acquired - Sep 14, 2016
Vitae Pharmaceuticals— Acquired
- Sep 20, 2016
Akarna Therapeutics— Acquired
- Sep 20, 2016
Tobira Therapeutics, Inc.— Acquired
- Oct 27, 2016
Motus Therapeutics, Inc.— Acquired - Nov 22, 2016
Chase Pharmaceuticals Corporation— Acquired
- Dec 20, 2016
LifeCell— Acquired
- Feb 13, 2017
Zeltiq Aesthetics— Acquired
- Jun 7, 2017
Keller Medical, Inc.— Acquired - Dec 1, 2017
Repros Therapeutics— Acquired
- Feb 7, 2018
Elastagen— Acquired
- Sep 14, 2018
Bonti, Inc.— Acquired - Oct 1, 2018
sarecycline hydrochloride— NDA Organization
- Mar 26, 2019
Envy Medical, Inc.— Acquired
- Apr 26, 2019
bosentan— Marketing Organization
- Jun 26, 2019
AbbVie— Acquired By
Drugs by trial phase (385 distinct, 1113 trials)
Phase 4 (4 own, 62 via acquisition)
Phase 3 (0 own, 113 via acquisition)
Phase 2 (4 own, 101 via acquisition)
Phase 1 (1 own, 77 via acquisition)
Indications
Marketed drugs (107)
Subsidiaries (22 direct, 110 total across the full acquisition tree)
- Actavis
- Akarna Therapeutics
- Anterios
- AqueSys
- Bonti, Inc.
- Chase Pharmaceuticals Corporation
- Elastagen
- Envy Medical, Inc.
- ForSight Vision 5
- Inamed GmbH
- Keller Medical, Inc.
- Kythera
- LifeCell
- Motus Therapeutics, Inc.
- Naurex
- Oculeve
- Repros Therapeutics
- RetroSense Therapeutics
- Tobira Therapeutics, Inc.
- Topokine Therapeutics
- Vitae Pharmaceuticals
- Zeltiq Aesthetics
- Auden Mckenzie Holdings Ltd. L2
- Durata L2
- Forest Laboratories L2
- Lotus Labs L2
- Regado Biosciences L2
- Silom Medical Company L2
- Warner Chilcott L2
- Watson Pharmaceuticals L2
- Actavis Group (1956) L3
- Andrx L3
- Aptalis L3
- Ascent Pharmahealth L3
- Cerexa L3
- Circa Pharmaceuticals L3
- Clinical Data, Inc. L3
- Eden Biodesign L3
- Furiex L3
- Galen L3
- Halsey L3
- Henry Schein, Inc L3
- Nalé Laboratories, PLC L3
- Oclassen L3
- Procter and Gamble L3
- Specifar Pharmaceuticals S.A. L3
- Uteron Pharma S.A. L3
- Accord Dental L4
- Alpha Scientific L4
- Arcona L4
- Armstrong Pharmaceuticals L4
- Ash Temple L4
- Axcan L4
- Barton-Cyker Dental Supply L4
- Butler Animal Health L4
- Caligor Hospital L4
- Colonial Surgical L4
- CTEX Pharmaceuticals L4
- Dentrix Dental Systems L4
- Eurand Pharmaceuticals L4
- Genaissance L4
- GIV L4
- Hager Dental L4
- Halas Dental L4
- Heiland L4
- ImproMed L4
- Krugg L4
- Lincoln Dental Supply L4
- Maravet L4
- Marsam Pharmaceuticals L4
- McAllister Software Systems L4
- Medivet S.A. L4
- Medka L4
- Meer Dental L4
- Minerva Dental, Ltd L4
- Modern Laboratory Services L4
- New Chapter Inc L4
- Nioxin Research Laboratories L4
- NLS Animal Health L4
- Norwich Eaton Company L4
- Noviko L4
- Noxell L4
- Ortho Oganizers L4
- Ortho Technology L4
- Permira L4
- Provet Holding AG L4
- Regional Healthcare (Australia) L4
- Richardson Vicks Inc L4
- RxWorks L4
- Scil Technology GmbH L4
- Shalfoon Brothers L4
- Software of Excellence International, Ltd. L4
- Sogim Grimouille L4
- Sullivan Dental Products L4
- Thomas Hedley Co L4
- Vertex L4
- W&J Dunlop Ltd L4
- Zahn Dental L4
- Alpine Immune Sciences L5
- Aurora Biosciences L5
- Exonics L5
- J.T. Baker Chemical Company L5
- Milton Antiseptic L5
- Muller & Weygandt L5
- Prince Matchabelli Perfume Company L5
- Semma Therapeutics L5
- ViaCyte L5
- ViroChem Pharma L5
- William S. Merrell Company L5
- Nivalis Therapeutics, Inc. L6
Recent trials (18)
- NCT03573297Study directorPhase 3Jun 15, 2018
- NCT03339999Lead sponsorPhase 2Nov 15, 2017
- NCT02792803Sponsor investigatorPhase 4Sep 1, 2015
- NCT03724292Lead sponsorPhase 1Aug 1, 2015
- NCT02381795Lead sponsorPhase 2Jul 1, 2015
- NCT02176018Lead sponsorPhase 2Aug 1, 2014
- NCT02176655Lead sponsorPhase 2Jul 1, 2014
- NCT02037425Lead sponsorPhase 4Apr 1, 2014
- NCT02152007Lead sponsorPhase 1Jan 1, 2014
- NCT02152007Study chairPhase 1Jan 1, 2014
- NCT01700387Lead sponsorPhase 4Oct 1, 2012
- NCT01329562Lead sponsorPhase 4May 1, 2011
- NCT01300546Lead sponsorPhase 4Dec 1, 2010
- NCT01090050Lead sponsorPhase 4Sep 1, 2010
- NCT01071096Lead sponsorPhase 4Jun 1, 2010
Details
- Founded
- Dublin, IE Jan 1, 2015
- First NDA
- Oct 1, 2018
- Last known activity
- Jun 24, 2019